Haeseong Park
Brigham and Women's Hospital(US)Harvard University(US)Dana-Farber Cancer Institute(US)Dana-Farber Brigham Cancer Center(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Hemoglobinopathies and Related Disorders, HER2/EGFR in Cancer Research, Gastric Cancer Management and Outcomes, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,640 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology(2019)1,084 cited
- → Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low–Expressing Advanced Breast Cancer: Results From a Phase Ib Study(2020)797 cited
- → Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer(2019)420 cited
- → Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors(2020)345 cited
- → Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study(2019)343 cited